2026年议长局基准报告

CLARA GOMES, Assoc. Director, Operational Effectiveness, Speaker Bureau, IQVIATIFFANY GALLO, Director, Customer Success, Speaker Bureau, IQVIAHEATHER MURRAY, Director, Customer Success, Speaker Bureau, IQVIAJAMES CONSOLE, Director, Strategic Operations, Speaker Bureau, IQVIA Table of contents Introduction1Evaluation methodology1Therapeutic area reclassification2Live programs’ continued strength3Live programs’ edge continued4Costs increased for most program types8Speaker fees varied across therapeutic areas10Conclusion12Appendix13Cardiovascular/Metabolic13Infectious disease/immunology14Neurology/psychiatry16Oncology18Respiratory19About the authors21 Introduction The 2026 Speaker Bureau Benchmarks Report provides an updated view ofprogram performance across IQVIA’s portfolio, highlighting trends in mix,attendance, costs, and therapeutic-area dynamics based on completed 2025program activity. While overall engagement volume declined modestly, thestructure of the channel remains stable. Live formats continued to anchorengagement across therapeutic areas, and Virtual programs maintained theirrole as scalable formats that expand reach. Performance across therapeutic areas reflects amaturing and an increasingly predictable environment.Most therapeutic areas clearly exhibit expected launchand post-launch patterns. At the same time, rapidlyexpanding areas such as neurology and respiratorycontinued to grow, contributing meaningfully to demandand engagement. Cost patterns varied by format, withinflationary pressure raising Live program costs, whileincreasing operational efficiencies drove down VirtualLink programs costs. A review of the data by therapeutic area shows thatneurology and respiratory had notable increases inprogram volume. In contrast, cardiovascular, metabolic,and oncology saw declines in program volume, witha notable move toward Virtual programs, particularlythose using Virtual Link. Evaluation methodology This report analyzes the following categories of IQVIA’sSpeaker Bureau business: Live Out-of-Office, Live In-Office,Virtual Host (speaker presenting via a Virtual platform), andVirtual Link (attendees viewing the Virtual Host programvia a Virtual platform, either in a Virtual or Live setting). Collectively, the insights presented in this reportillustrate a resilient, adaptable, and effective channel.The insights that follow are designed to supportplanning, inform program strategies, and guide decisionmaking as Speaker Bureau engagement continues toevolve in 2026 and beyond. The analyses include: •IQVIA Speaker Bureau customers•Completed programs•Programs held within the specified year/month Therapeutic area expansion Across therapeutic areas, 2024–2025 shifts reflect acontinued broad return to in-person engagement ledby strong gains in Live Out-of-Office for cardiovascularand metabolic, with Virtual displacement in neurology,continued Live strength in oncology, and sustainedvolume growth in respiratory. Respiratory was introduced as an emerging therapeuticarea in this report. Its addition reflects significantexpansion observed in 2024, marked by a sharp risein program activity with continued growth in 2025.Incorporating the respiratory therapeutic area enablesus to highlight evolving trends and underscore itsincreasing strategic importance. Data continues to be presented in the blinded,aggregated format used historically, with the potential tointroduce updated segmented views in the future. Live programs’ continued strength Across the 2021-2025 period, overall program mixexhibited modest year-over-year shifts, reinforcing thestability of delivery preferences across the portfolio. Theaggregate changes appear empirically small with therelative positioning of Live and Virtual formats reflectingongoing strategic refinement rather than structuraltransformation. Virtual formats, especially Virtual Links, continued to serve as a flexible complement to Liveprograms, enabling customers to extend reach throughVirtual Host and Virtual Link-style models that maximizethe impact of high-value Live Out-of-Office and LiveIn-Office events. This nuanced interplay suggests thatVirtual is increasingly being leveraged not as a substitutefor Live delivery, but as an amplifier of its strengths. Live programs’ edge continued 2024 vs. 2025 analysis The Virtual share of program volume declined slightlyyear-over-year, except for a brief increase in the summermonths that boosted attendance. May did not showits usual peak in Virtual activity, and November shiftedback to Live events due to fewer marketing-led Virtual programs. February and September continued to favorVirtual formats, aligning with major broadcast events.Overall, these trends reflect healthcare professionals’ongoing preference for in-person programs that fostereducation and peer engagement. program activity observed in our last report appears to bepersisting. Elevated volume continued from June throughAugust relative to historical norms, suppo